Financials

  • Market Capitalization 832.37 K
  • Employee 45
  • Founded 2003
  • CEO N/A
  • Website www.scinai.com
  • Headquarter Israel
  • FIGI BBG007TGL1R2
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
791.22
Price to sales ratio
5 072.94

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
5150
SLXN
Silexion Therapeutics Corp - Ordinary Shares
2.54 USD-1.93%-6.27%-20.63%+57.76%1.06 M USD
5156
ONCO
Onconetix, Inc. - Common Stock
0.86 USD-8.51%-18.10%-18.87%+13.16%985.95 K USD
5198
BDRX
Biodexa Pharmaceuticals plc - American Depositary Shares
2.31 USD-7.23%-19.51%-25.48%+65.00%208.66 K USD
5203
ARMP
Armata Pharmaceuticals, Inc. Common Stock
4.00 USD-6.10%-27.01%-46.95%-51.06%146.84 K USD

Frequently asked questions about Scinai Immunotherapeutics Ltd - American Depositary Shares

What is the Scinai Immunotherapeutics Ltd - American Depositary Shares stock price today?

The current price of Scinai Immunotherapeutics Ltd - American Depositary Shares (SCNI) is 0.24. Over the past 24 hours, the stock has changed by -4.00%. Follow the SCNI chart for real-time price dynamics.

What is the stock ticker of Scinai Immunotherapeutics Ltd - American Depositary Shares?

Scinai Immunotherapeutics Ltd - American Depositary Shares trades under the ticker SCNI. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Scinai Immunotherapeutics Ltd - American Depositary Shares stock going up?

SCNI has changed by -7.69% over the last week, -29.41% over the last month, and -68.26% over the last year. Review the chart to see whether the current move is part of a broader trend.

How many employees does Scinai Immunotherapeutics Ltd - American Depositary Shares have?

As of the latest available data, Scinai Immunotherapeutics Ltd - American Depositary Shares has 45 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Scinai Immunotherapeutics Ltd - American Depositary Shares stock?

You can buy Scinai Immunotherapeutics Ltd - American Depositary Shares (SCNI) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Scinai Immunotherapeutics Ltd - American Depositary Shares stock?

Investing in Scinai Immunotherapeutics Ltd - American Depositary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SCNI chart and related analysis on metatrader.com as part of your research.

Scinai Immunotherapeutics Ltd - American Depositary Shares

BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases. In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis.

News